Table 4 of Park, Mol Vis 2009; 15:200-207.
Subject group (genotyping platform) |
Mayo subjects (TaqMan) |
AREDS subjects (TaqMan) |
Ennis et al. (UK) subjects (Illumina) |
Ennis et al. (US) subjects (TaqMan) |
||||
---|---|---|---|---|---|---|---|---|
Subjects | Case | Control | Case | Control | Case | Control | Case | Control |
No. of participants | 470 | 310 | 1221 | 295 | 479 | 479 | 248 | 252 |
Allele count (%) | ||||||||
G | 569 (61) | 363 (59) | 1435 (59) | 357 (61) | 597 (63) | 500 (52) | 322 (65) | 282 (56) |
A | 371 (39) | 257 (41) | 1007 (41) | 233 (39) | 355 (37) | 454 (48) | 174 (35) | 222 (44) |
Genotype count (%) | ||||||||
GG | 179 (38) | 103 (33) | 436 (36) | 115 (39) | 191 (40) | 132 (28) | 100 (40) | 79 (31) |
GA | 211 (45) | 157 (51) | 563 (46) | 127 (43) | 215 (45) | 236 (50) | 122 (49) | 124 (49) |
AA | 80 (17) | 50 (16) | 222 (18) | 53 (18) | 70 (15) | 109 (23) | 26 (11) | 49 (19) |
P-values | ||||||||
Allele | 0.46 | – | 0.41 | – | 5.4E-06 | – | 0.0037 | – |
Genotype | 0.44 | – | 0.45 | – | 4.0E-05 | – | 0.0080 | – |